GEN: Top 20 R&D Spenders among Life Science Companies
Like pharmaceutical companies, life science tool and technology companies are also experiencing a wave of cost spiral and consolidation in recent years. Among these top 20 companies on this year’s ...
Obesity Gene? Now You Find Something to Blame
Obesity not only affects the self image but also is harmful to health—it increases risks of diabetes, heart disease, and some forms of cancer. However, losing weight is not an easy task. In order to ...
The "Gateway" Allows Cancer Cells to Spread to Blood Vessels
Recently, scientists used real-time, high-resolution imaging technology to determine a a "gateway" in the vasculature, allowing cancer cells to spread from the breast to other parts of the body. ...
New Finding: the Origins of Breast Tumor Cells
A key issue for tumor biology is to understand the mechanisms controlling tumor heterogeneity, and to determine the extent of tumor heterogeneity that will affect the clinical outcome. In a recent ...
Ten Simple Rules to Win a Nobel Prize
Undoubtedly, there are too many people walking on the way of pursuing the Nobel Prize. Some of them are young scientists, writers, students, and even the senior scientists. A "Nobel Prize" shows too ...
Global Gene Therapy Deals in 2014 Skyrocketed to Nearly $5 Billion
According to GlobalData's research data, the total number of deals in the global gene therapy market has increased from 16 cases in 2013 to 36 cases in 2014, with the combined value soared from $ ...
How Is the Medtronic's M&A Strategy Involving in the Medical Device World?
In recent years, the med-tech industry has witnessed quite a lot of biopharma mergers and acquisitions (M with non-GAAP $ 4.744 billion and $ 4.28 per share, respectively rose by 16% and 6%.So who ...
The Most Read Cell Stem Cell Articles in July
Cell Stem Cell is one of the two newly added members in Cell Press in 2007, (the other is the Cell Host but these methods do not promote cell maturation. On iPSCs, the laboratory used a way to let ...
Global Diabetes Market Have Reached $62 Billion in 2014
According to a report compiled by data analytics firm GlobalData, the top ten diabetes drug manufacturers have generated a total of $ 62 billion in 2014 global sales, a rise of 5.1% year-on-year. ...
Significant Progress: Antibody Drugs for Alzheimer’s Show Glimmers of Promise
Alzheimer's disease drug development seems like the Bermuda for clinical-trial—over an hundred and twenty clinical trials have sunk like a stone in the past two decades. A handful of approved drugs ...